Back to Search
Start Over
[Pulmonary arterial hypertension from the risk assessment to combined treatment].
- Source :
-
Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2019 Sep 02; Vol. 57 (5), pp. 314-323. Date of Electronic Publication: 2019 Sep 02. - Publication Year :
- 2019
-
Abstract
- This paper shows the importance of the guideline clinical practice as well as the centers for comprehensive care of pulmonary arterial hypertension. The current treatment of pulmonary arterial hypertension is analyzed according to its severity, stratified through the evaluation of the multiple parameters of risk and its mortality to 1 year. The prognosis of the disease is considered and the place of the combined treatment indicated in sequential manner or from the beginning.
- Subjects :
- Drug Therapy, Combination methods
Endothelin Receptor Antagonists therapeutic use
Enzyme Activators therapeutic use
Epoprostenol analogs & derivatives
Humans
Phosphodiesterase 5 Inhibitors therapeutic use
Prognosis
Pulmonary Arterial Hypertension etiology
Randomized Controlled Trials as Topic
Risk Assessment
Antihypertensive Agents therapeutic use
Pulmonary Arterial Hypertension drug therapy
Subjects
Details
- Language :
- Spanish; Castilian
- ISSN :
- 2448-5667
- Volume :
- 57
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Revista medica del Instituto Mexicano del Seguro Social
- Publication Type :
- Academic Journal
- Accession number :
- 32568487